RenovaCare Inc
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to… Read more
RenovaCare Inc (RCAR) - Net Assets
Latest net assets as of September 2022: $-1.46 Million USD
Based on the latest financial reports, RenovaCare Inc (RCAR) has net assets worth $-1.46 Million USD as of September 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.06 Million) and total liabilities ($2.52 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.46 Million |
| % of Total Assets | -138.31% |
| Annual Growth Rate | 2.91% |
| 5-Year Change | 41.0% |
| 10-Year Change | 142.51% |
| Growth Volatility | 2954.18 |
RenovaCare Inc - Net Assets Trend (1998–2021)
This chart illustrates how RenovaCare Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RenovaCare Inc (1998–2021)
The table below shows the annual net assets of RenovaCare Inc from 1998 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | $2.35 Million | -66.85% |
| 2020-12-31 | $7.08 Million | -41.79% |
| 2019-12-31 | $12.16 Million | -20.66% |
| 2018-12-31 | $15.33 Million | +820.79% |
| 2017-12-31 | $1.66 Million | +595.50% |
| 2016-12-31 | $239.33K | +6.39% |
| 2015-12-31 | $224.95K | -52.58% |
| 2014-12-31 | $474.34K | -72.06% |
| 2013-12-31 | $1.70 Million | +75.40% |
| 2012-12-31 | $967.76K | -20.13% |
| 2011-12-31 | $1.21 Million | +137.38% |
| 2010-12-31 | $-3.24 Million | -405.54% |
| 2009-12-31 | $1.06 Million | -64.93% |
| 2008-12-31 | $3.03 Million | +14173.93% |
| 2007-12-31 | $21.19K | -53.80% |
| 2006-12-31 | $45.88K | -97.01% |
| 2005-12-31 | $1.53 Million | +257.09% |
| 2004-12-31 | $429.13K | -10.23% |
| 2003-12-31 | $478.02K | -54.29% |
| 2002-12-31 | $1.05 Million | +3.18% |
| 2001-12-31 | $1.01 Million | -23.88% |
| 2000-12-31 | $1.33 Million | -37.54% |
| 1999-12-31 | $2.13 Million | +75.60% |
| 1998-12-31 | $1.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to RenovaCare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3341194500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $874.00 | 0.04% |
| Other Components | $36.59 Million | 1558.91% |
| Total Equity | $2.35 Million | 100.00% |
RenovaCare Inc Competitors by Market Cap
The table below lists competitors of RenovaCare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Photocat AS
ST:PCAT
|
$2.25K |
|
SAGGD
OTCQB:SAGGD
|
$2.25K |
|
PADAENG IND NVDR
MU:QU5A
|
$2.25K |
|
ISDN HLDGS (I8D.SG)
STU:I8D
|
$2.25K |
|
Tali Resources Ltd
AU:TR2
|
$2.24K |
|
BK NEGARA INDO -B-
MU:BKE1
|
$2.24K |
|
Amincor Inc
PINK:AMNCB
|
$2.24K |
|
Powertap Hydrogen Capital Corp
PINK:MOTNF
|
$2.24K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RenovaCare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 7,078,775 to 2,346,889, a change of -4,731,886 (-66.8%).
- Net loss of 4,465,306 reduced equity.
- Other factors decreased equity by 266,580.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.47 Million | -190.26% |
| Other Changes | $-266.58K | -11.36% |
| Total Change | $- | -66.85% |
Book Value vs Market Value Analysis
This analysis compares RenovaCare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $0.05 | $0.00 | x |
| 1999-12-31 | $0.09 | $0.00 | x |
| 2000-12-31 | $0.11 | $0.00 | x |
| 2001-12-31 | $0.09 | $0.00 | x |
| 2002-12-31 | $0.07 | $0.00 | x |
| 2003-12-31 | $0.00 | $0.00 | x |
| 2004-12-31 | $0.00 | $0.00 | x |
| 2005-12-31 | $0.02 | $0.00 | x |
| 2006-12-31 | $0.00 | $0.00 | x |
| 2007-12-31 | $0.00 | $0.00 | x |
| 2008-12-31 | $0.05 | $0.00 | x |
| 2009-12-31 | $0.02 | $0.00 | x |
| 2010-12-31 | $-0.05 | $0.00 | x |
| 2011-12-31 | $0.02 | $0.00 | x |
| 2012-12-31 | $0.02 | $0.00 | x |
| 2013-12-31 | $0.03 | $0.00 | x |
| 2014-12-31 | $0.01 | $0.00 | x |
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.02 | $0.00 | x |
| 2018-12-31 | $0.20 | $0.00 | x |
| 2019-12-31 | $0.14 | $0.00 | x |
| 2020-12-31 | $0.08 | $0.00 | x |
| 2021-12-31 | $0.03 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RenovaCare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -190.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.56x
- Recent ROE (-190.26%) is below the historical average (-111.34%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -19.07% | -349.08% | 0.05x | 1.01x | $-353.48K |
| 1999 | -33.31% | 0.00% | 0.00x | 1.01x | $-922.71K |
| 2000 | -57.95% | -501.95% | 0.11x | 1.08x | $-904.69K |
| 2001 | -31.37% | -68.63% | 0.38x | 1.19x | $-419.31K |
| 2002 | -25.09% | -28.54% | 0.80x | 1.09x | $-366.97K |
| 2003 | -146.40% | 0.00% | 0.00x | 1.07x | $-747.62K |
| 2004 | -40.79% | 0.00% | 0.00x | 1.07x | $-217.96K |
| 2005 | -4.44% | 0.00% | 0.00x | 1.03x | $-221.20K |
| 2006 | -98.10% | 0.00% | 0.00x | 1.84x | $-49.59K |
| 2007 | -116.46% | 0.00% | 0.00x | 2.18x | $-26.80K |
| 2008 | -8.76% | -1925.56% | 0.00x | 1.02x | $-567.67K |
| 2009 | 119.66% | 2482.79% | 0.02x | 2.37x | $1.16 Million |
| 2010 | 0.00% | -10707.79% | 0.02x | 0.00x | $-3.94 Million |
| 2011 | 367.87% | 13595.58% | 0.02x | 1.11x | $4.34 Million |
| 2012 | -25.21% | -1251.46% | 0.02x | 1.10x | $-340.73K |
| 2013 | -60.84% | 0.00% | 0.00x | 1.03x | $-1.20 Million |
| 2014 | -449.34% | 0.00% | 0.00x | 1.80x | $-2.18 Million |
| 2015 | -586.13% | 0.00% | 0.00x | 2.49x | $-1.34 Million |
| 2016 | -868.22% | 0.00% | 0.00x | 2.52x | $-2.10 Million |
| 2017 | -221.65% | 0.00% | 0.00x | 1.84x | $-3.86 Million |
| 2018 | -13.84% | 0.00% | 0.00x | 1.03x | $-3.65 Million |
| 2019 | -27.62% | 0.00% | 0.00x | 1.02x | $-4.57 Million |
| 2020 | -134.89% | 0.00% | 0.00x | 1.19x | $-10.26 Million |
| 2021 | -190.26% | 0.00% | 0.00x | 1.56x | $-4.70 Million |
Industry Comparison
This section compares RenovaCare Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RenovaCare Inc (RCAR) | $-1.46 Million | -19.07% | N/A | $2.25K |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |